CG
TXG icon

Cutler Group’s 10x Genomics TXG Stock Holding History

Cutler Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-800
Closed -$1K – 5240
2022
Q3 		$1K Buy
+800
New +$30.5K ﹤0.01% 4711
2022
Q2 		– Sell
-400
Closed -$1K – 5693
2022
Q1 		$1K Sell
400
-2,700
-87% -$236K ﹤0.01% 5095
2021
Q4 		$17K Sell
3,100
-3,100
-50% -$475K ﹤0.01% 3266
2021
Q3 		$14K Buy
6,200
+6,100
+6,100% +$1.05M ﹤0.01% 3669
2021
Q2 		$6K Buy
+100
New +$18.1K ﹤0.01% 4344
2021
Q1 		– Sell
-5,200
Closed -$9K – 6311
2020
Q4 		$9K Sell
5,200
-6,100
-54% -$885K ﹤0.01% 3286
2020
Q3 		$266K Sell
11,300
-300
-3% -$31.5K 0.02% 791
2020
Q2 		$98K Buy
11,600
+9,400
+427% +$732K 0.01% 1323
2020
Q1 		$10K Buy
+2,200
New +$172K ﹤0.01% 2730

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Cutler Group's TXG Position: Q1 2023 in Review

Cutler Group sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 2,300 shares — an estimated $83K sold.

Cutler Group first reported a position in TXG in Q4 2019 and held it in 11 quarters. The position peaked at $512K in Q4 2020. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

  • Cutler Group reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 2,300 10x Genomics shares in Q1 2023, an estimated $83K.
  • Cutler Group first reported a position in 10x Genomics in Q4 2019 and held it in 11 quarters.
  • Cutler Group's 10x Genomics position peaked at $512K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.